GlassScriptPhysician profile
Prafull Raheja
NPI 1679732051
$26,592.84
in general payments reported to CMS, 2019-2025
40 companies · $1,851 in 2025
The $1,851 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,755 · 2020: $2,871 · 2021: $2,303 · 2022: $1,848 · 2023: $13K · 2024: $1,902 · 2025: $1,851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $5,976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,838.92 |
| Food and Beverage | $5,976.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,826.66 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Ffrangio |
| Abbott Laboratories | $2,405.17 | 2021-2025 | Diamondback Coronary, Coroflow, Perclose Prostyle |
| Edwards Lifesciences Corporation | $1,599.47 | 2020-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $1,243.36 | 2019-2025 | |
| Medtronic Vascular, INC. | $1,225.78 | 2019-2020 | |
| Terumo Medical Corporation | $1,211.61 | 2019-2025 | Metacross Otw, Angio-Seal, Glidewire |
| Janssen Pharmaceuticals, INC | $1,185.80 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $973.13 | 2020-2025 | Ekosonic, Watchman Flx, Eluvia |
| Astrazeneca Pharmaceuticals LP | $734.34 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Pfizer INC. | $631.15 | 2021-2025 | |
| Chiesi USA, INC. | $564.75 | 2019-2025 | Kengreal, Cleviprex |
| Cardiovascular Systems INC. | $509.78 | 2019-2023 | Diamondback Coronary |
| Amgen INC. | $298.50 | 2019-2025 | Repatha, Repatha |
| Abiomed | $275.98 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $241.86 | 2021-2025 | Verquvo |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $232.56 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $169.38 | 2022-2025 | Camzyos, Eliquis |
| Ekos Corporation | $124.18 | 2019 | |
| Philips North America LLC | $119.34 | 2019-2023 | |
| Cvrx, INC. | $112.98 | 2021-2023 | Barostim Neo System |
| Medicure Pharma INC. | $100.67 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $84.74 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $83.32 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $75.83 | 2023-2025 | Onpattro |
| Scpharmaceuticals INC. | $60.24 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $59.47 | 2019-2023 | Opsumit, Uptravi |
| Teleflex LLC | $56.05 | 2020-2023 | Manta, Raider |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.96 | 2019-2025 | Jardiance |
| Zoll Circulation INC | $49.87 | 2021-2022 | |
| Vital Connect, INC | $41.85 | 2023 | Vitalpatch Rtm |
| Kestra Medical Technology Services, INC. | $39.34 | 2024 | Assure Wcd |
| Glaxosmithkline, LLC. | $38.66 | 2025 | Shingrix, Arexvy |
| Novo Nordisk INC | $30.57 | 2023-2024 | Rybelsus, Ozempic |
| Silk Road Medical, INC. | $23.87 | 2022 | |
| Heartflow, INC. | $21.87 | 2025 | |
| Inari Medical, INC. | $19.35 | 2022 | |
| W. L. Gore & Associates, INC. | $19.11 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Livanova USA, INC. | $17.90 | 2022 | |
| Thrombolex, INC. | $16.43 | 2025 | Bashir Endovascular Catheter |
| Esperion Therapeutics, INC. | $15.96 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prafull Raheja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.